| ¿µ¹® | Gram stain | ÇÑ±Û | ±×¶÷¿°»ö |
|---|---|---|---|
| ¼³¸í | ¹Ì»ý¹°À» ¿°»öÇÏ´Â ¹æ¹ý ÁßÀÇ Çϳª. 1884³â µ§¸¶Å©ÀÇ ÀÇ»ç H.C.J. ±×¶÷(1853~ 1938)ÀÌ °í¾ÈÇÑ Æ¯¼ö ¿°»ö¹ýÀÌ´Ù. ÀÌ ¿°»ö¹ýÀ» »ç¿ëÇÏ¸é ¹Ì»ý¹°Àº ¾ç¼º±Õ°ú À½¼º±ÕÀÇ 2¹«¸®·Î Å©°Ô ³ª´¶´Ù. ¿°»ö¹ýÀº ±ÕÀ» À¯¸®¸é¿¡ ¹Ù¸£°í °¡¿ °íÁ¤ÇÑ´Ù. Á¨½Ã¾È¹ÙÀÌ¿À·¿, Å©¸®½ºÅ» ¹ÙÀÌ¿À·¿, ¸ÞÆ¿¹ÙÀÌ¿À·¿ µî ÆÄ¶ó·ÎÁî ¾Æ´Ò¸°°è »ö¼ÒÀÇ ¾î´À Çϳª¸¦ »ç¿ëÇÏ¿© ¿ì¼± ¿°»öÇϰí ÀÌ¾î¼ ·ç°ñ¾×À» ÀÛ¿ë½ÃŲ µÚ, ¿¡Åº¿Ã ¶Ç´Â ¾Æ¼¼ÅæÀ¸·Î Å»»öÇÑ´Ù. À̶§ Å»»öµÇÁö ¾Ê°í º¸¶ó»öÀ» Ÿ³ª³»´Â °ÍÀ» ±×¶÷¾ç¼º±ÕÀ̶ó ºÎ¸£¸ç, Æ÷µµ¾Ë±Õ-Æó·Å¾Ë±Õ-»ç½½¾Ë±Õ µîÀÌ ´ëÇ¥ÀûÀÎ ¿¹ÀÌ´Ù. Å»»öµÇ¸é ±×¶÷À½¼º±ÕÀ̶ó ºÎ¸£¸ç, ´ëÀå±Õ-³ì³ó±Õ µîÀÌ ÀÖ´Ù. ÃÖÈÄ¿¡ »çÇÁ¶ó´Ñ, Ç«½Å µî Àû»ö°èÀÇ »ö¼Ò¾×À¸·Î ÈÄ¿°»öÀ» ÇÑ´Ù. ¹Ì»ý¹°ÀÇ °¨º°¿¡ Áß¿äÇÑ ¿°»ö¹ýÀÌ¸ç ¿°»ö¼ºÀÇ Â÷ÀÌ´Â ¿µ¾ç¿ä±¸¼º, ÈÇпä¹ýÁ¦(Ç×»ý¹°Áú µî)¿¡ ´ëÇÑ °¨¼ö¼ºÀÇ Â÷À̿͵µ °ü·ÃµÇ´Â Á¡ÀÌ ¸¹À¸¹Ç·Î »ç¿ë¾àÁ¦ÀÇ ¼±Åýÿ¡µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. ±×¶÷¾ç¼º±Õ°ú À½¼º±ÕÀÇ Â÷ÀÌ´Â ¼¼±Õº®ÀÇ ±¸Á¶¿¡ Àִµ¥, ¾ç¼º±ÕÀº ¼¼Æ÷¸·ÀÇ ¹Ù±ùÂÊ ÆéƼµå±Û¸®ÄÀ̶ó´Â ´ç´Ü¹éÁúÃþÀÇ µÎ²²°¡ 20~80nm³ª µÇ°í, ±×·¥À½¼º±ÕÀÇ ÆéƼµå±Û¸®Ä ÃþÀº 2~3nm·Î ¾ã°í, ´Ù½Ã ¹Ù±ùÂÊ¿¡ ¿Ü¸·À̶ó ºÎ¸£´Â ÃþÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | fibrin | ÇÑ±Û | ¼¶À¯¼Ò |
|---|---|---|---|
| ¼³¸í | Çǰ¡ ±»À» ¶§ ¼¶À¯¼Ò¿¡ Æ®·ÒºóÀÌ ÀÛ¿ëÇÏ¿© »ý±â´Â ¼¶À¯ °°Àº ´Ü¹éÁú. ¹«»öÀ̳ª ¿¯Àº Ȳ»öÀ» ¶í °íü·Î, ¹°¿¡ Àß ³ìÁö ¾ÊÀ¸¸ç Ç÷±¸¿Í ¾ûŰ¾î ÇǸ¦ ±»°Ô ÇÏ¿© ÃâÇ÷À» ±×Ä¡°Ô ÇÑ´Ù. |
||
| AFB Stain | Acid Fast Bacilli Stain |
|---|---|
| HE stain | Hematoxylin-Eosin stain |
| SFC | soluble fibrin complex; soluble fibrin-fibrinogen complex; spinal fluid count |
| WS | Waardenburg syndrome; ward secretary; Warkany syndrome; Warthin-Starry [stain]; water soluble; water... |
| FSF | Fibrin Stabilizing Factor(Factor XIII) |
| PWS | Port Wine Stain |
|---|---|
| FDP | Fibrin Degradation Product |
| FbDP | Fibrin Degradation Products |
| FS | Fibrin Sealant |
| FG | Fibrin glue |
| Weigert-Gram stain | <technique> A stain for bacteria in tissues in which sections are stained in alum-haematoxylin, then in eosin, aniline methyl violet, and Lugol's solution. (05 Mar 2000) |
|---|---|
| Weigert's iron haematoxylin stain | <technique> A nuclear staining solution containing haematoxylin, ferric chloride, and hydrochloric acid; useful in combination with von Gieson's stain, especially for demonstrating connective tissue elements or Entamoeba histolytica in sections. (05 Mar 2000) |
| Weigert's stain | <technique> 1. For actinomyces, a staining method using immersion in a dark red orsellin solution in alcohol, then staining in crystal-violet solution. See: iron haematoxylin. 2. For elastin, a staining solution of fuchsin, resorcin, and ferric chloride; elastic fibres stain blue-black. 3. For fibrin, a staining method using solutions of aniline-crystal violet and iodine-potassium iodide, then decolorizing in aniline oil and xylol; the fibrin is stained dark blue. 4. For myelin, a staining method using ferric chloride and haematoxylin; myelin stains deep blue, degenerated portions a light yellowish colour. 5. For neuroglia, a complicated process in which the final treatment is like that for staining fibrin; neuroglia and nuclei stain blue. 6. For reticulum, a silver impregnation technique in which reticulum appears as black, well-defined fibres without beading and with a relatively clear background. (05 Mar 2000) |
| Weigert, Carl | <person> German pathologist, 1845-1904. See: Weigert's law, Weigert's iodine solution. See entries under stain. (05 Mar 2000) |
| weigert-meyer rule | <radiology> Applies to duplex collecting systems, upper-pole ureter, obstruction most likely to be hydronephrosis, inserts more inferiorly and medially in bladder, may insert into urethra, vagina, etc., males not incontinent: insertion above ext. Sphincter, associated with ureterocele, lower-pole ureter, reflux most likely to be pyelonephritis see also: drooping lily sign (12 Dec 1998) |
| Weigert's iodine solution | An iodine-potassium iodide mixture used as a reagent to alter crystal and methyl violet so that they are retained by certain bacteria and fungi. (05 Mar 2000) |
| Weigert's law | The loss or destruction of a part or element in the organic world is likely to result in compensatory replacement and overproduction of tissue during the process of regeneration or repair (or both), as in the formation of callus when a fractured bone heals. Synonym: overproduction theory. (05 Mar 2000) |
| human fibrin foam | A dry artificial sponge of human fibrin prepared by clotting with thrombin a foam of a solution of human fibrinogen; the clotted foam is dried from the frozen state and heated; used as a topical anticoagulant. (05 Mar 2000) |
| fibrin | <protein> The insoluble protein formed from fibrinogen by the proteolytic action of thrombin during normal clotting of blood. Fibrin forms the essential portion of the blood clot. (12 Nov 1997) |
| fibrin calculus | A urinary calculus formed largely from fibrinogen in blood. (05 Mar 2000) |
| fibrin degradation products | <haematology, investigation> A test that measures fibrin degradation products which result from the dissolution of a blood clot. Normal value is less than 10 mcg/ml (micrograms per millilitre). They may be increased in conditions such as burns, placental abruption, heart disease, DIC, after massive blood transfusion, hypoxia, intrauterine foetal death, portacaval shunt, leukaemia, transfusion reaction, transplant rejection, sepsis, renal failure and preeclampsia. Acronym: FDP (23 Sep 2002) |
| fibrin destabilase | <enzyme> Hydrolyses the epsilon-(gamma-glutamyl)-lysine bonds of stabilised fibrin Pharmacological action: fibrinolytic agents Registry number: EC 3.4.99.- Synonym: destabilase (26 Jun 1999) |
| fibrin fibrinogen degradation products | <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis. Pharmacological action: antithrombins. (12 Dec 1998) |
| fibrin foam | <chemical> A dry artificial sterile sponge of fibrin prepared by clotting with thrombin a foam or solution of fibrinogen. It is used in conjunction with thrombin as a haemostatic in surgery at sites where bleeding cannot be controlled by more common methods. Pharmacological action: haemostatics, tissue adhesives. (12 Dec 1998) |
| fibrinogen-fibrin conversion syndrome | <syndrome> A syndrome characterised by hypofibrinogenaemia with incoagulable blood; it may be seen in abruptio placentae, prolonged retention of a dead foetus in an Rh-isosensitised mother, haemolytic blood reactions, bilateral renal cortical necrosis, and cases of trauma. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|